Skip to main content

Advertisement

SpringerLink
Log in

SAPHO syndrome: current clinical, diagnostic and treatment approaches

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

This review provides an overview of SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis), a rare autoinflammatory disease that primarily affects bones, skin, and joints. We conducted a search on Medline/PubMed using keywords such as SAPHO syndrome, chronic recurrent multifocal osteitis/osteomyelitis, and related terms. SAPHO syndrome is rare, with a reported frequency of 1 in 10,000 in the Caucasian population. However, the actual incidence of SAPHO syndrome is unknown, and the incidence of the disease is likely higher. The pathogenesis of SAPHO syndrome remains incompletely understood. Current evidence suggests that SAPHO results from a complex interplay between immune dysregulation, genetic susceptibility, and environmental factors. It's not clear if SAPHO syndrome is an autoimmune disease or an autoinflammatory disease, but current evidence suggests that it's more likely an autoinflammatory disease because of things like neutrophil hyperactivity, fewer natural killer (NK) cells, high levels of interleukin (IL)-1, and a good response to treatments that block IL-1. Osteo-articular (OA) involvement is a key clinical feature of SAPHO. It affects the anterior chest wall, axial skeleton, peripheral joints, mandible, long bones of the extremities, and pelvis. Dermatological involvement is a common target in SAPHO, with lesions observed in 60–90% of cases. Common skin lesions include psoriasis and acne, with hidradenitis suppurativa and neutrophilic dermatoses being less commonly seen. Other clinical findings include constitutional symptoms caused by systemic inflammation, such as fever, weight loss, and fatigue. There is no specific laboratory finding for SAPHO syndrome. However, during active disease, there may be an increase in positive acute phase markers, such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), complement levels, mild leukocytosis, and thrombocytosis. Diagnosis is crucial for SAPHO syndrome, which lacks a specific diagnostic finding and is often underrecognized. A comprehensive evaluation of a patient's medical history and physical examination is crucial. Treatment options include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, conventional and synthetic disease-modifying agents (cDMARDs and sDMARDs), biological therapies, bisphosphonates, and antibiotics. Biological treatments have emerged as a viable alternative for SAPHO patients who do not respond to conventional treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Not applicable to this article as no datasets were generated during the current study.

References

  1. Carneiro S, Sampaio-Barros PD (2013) SAPHO syndrome. Rheum Dis Clin North Am 39:401–418. https://doi.org/10.1016/J.RDC.2013.02.009

    Article  PubMed  Google Scholar 

  2. Chamot AMKM (1994) SAPHO syndrome. Z Rheumatol 53(4):234–242

    CAS  PubMed  Google Scholar 

  3. Liu S, Tang M, Cao Y, Li C (2020) Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis. https://doi.org/10.1177/1759720X20912865

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nguyen MT, Borchers A, Selmi C et al (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254–265. https://doi.org/10.1016/J.SEMARTHRIT.2012.05.006

    Article  PubMed  Google Scholar 

  5. Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A (1987) [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic. 54(3):187–196

    CAS  PubMed  Google Scholar 

  6. Hedrich CM, Morbach H, Reiser C, Girschick HJ (2020) New insights into adult and paediatric chronic non-bacterial osteomyelitis CNO. Curr Rheumatol Rep 22(9):52. https://doi.org/10.1007/S11926-020-00928-1

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kahn MF, Khan MA (1994) The SAPHO syndrome. Baillieres Clin Rheumatol 8:333–362. https://doi.org/10.1016/S0950-3579(94)80022-7

    Article  CAS  PubMed  Google Scholar 

  8. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/S00296-011-1999-3

    Article  PubMed  Google Scholar 

  9. Przepiera-Bȩdzak H, Brzosko M (2021) SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review. Adv Dermatol Allergol 38:937. https://doi.org/10.5114/ADA.2020.97394

    Article  Google Scholar 

  10. Aljuhani F, Tournadre A, Tatar Z et al (2015) The SAPHO syndrome: a single-center study of 41 adult patients. J Rheumatol 42:329–334. https://doi.org/10.3899/JRHEUM.140342

    Article  PubMed  Google Scholar 

  11. Cao Y, Li C, Xu W et al (2019) Spinal and sacroiliac involvement in SAPHO syndrome: a single center study of a cohort of 354 patients. Semin Arthritis Rheum 48:990–996. https://doi.org/10.1016/J.SEMARTHRIT.2018.09.004

    Article  PubMed  Google Scholar 

  12. Colina M, Govoni M, Orzincolo C, Trotta F (2009) Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 61:813–821. https://doi.org/10.1002/ART.24540

    Article  PubMed  Google Scholar 

  13. Hayem G, Bouchaud-Chabot A, Benali K et al (1999) SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29:159–171. https://doi.org/10.1016/S0049-0172(99)80027-4

    Article  CAS  PubMed  Google Scholar 

  14. Berthelot JM, Corvec S, Hayem G (2018) SAPHO, autophagy, IL-1, FoxO1, and propionibacterium (Cutibacterium) acnes. Jt bone spine 85:171–176. https://doi.org/10.1016/J.JBSPIN.2017.04.010

    Article  CAS  Google Scholar 

  15. Ferguson PJ, Lokuta MA, El-Shanti HI et al (2008) Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 58:3264–3269. https://doi.org/10.1002/ART.23942

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gao S, Deng XL, Zhang L, Song L (2021) The comparison analysis of clinical and radiological features in SAPHO syndrome. Clin Rheumatol 40:349–357. https://doi.org/10.1007/S10067-020-05187-0

    Article  PubMed  Google Scholar 

  17. Rukavina I (2015) SAPHO syndrome: a review. J Child Orthop 9:19–27. https://doi.org/10.1007/S11832-014-0627-7

    Article  PubMed  PubMed Central  Google Scholar 

  18. Assmann G, Wagner AD, Monika M et al (2010) Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 30:1273–1276. https://doi.org/10.1007/S00296-009-1136-8

    Article  CAS  PubMed  Google Scholar 

  19. Hurtado-Nedelec M, Chollet-Martin S, Chapeton D et al (2010) Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol 37:401–409. https://doi.org/10.3899/JRHEUM.090456

    Article  CAS  PubMed  Google Scholar 

  20. Zimmermann P, Curtis N (2019) The role of Cutibacterium acnes in auto-inflammatory bone disorders. Eur J Pediatr 178:89–95. https://doi.org/10.1007/s00431-018-3263-2

    Article  CAS  PubMed  Google Scholar 

  21. Rozin AP (2009) SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended? Arthritis Res Ther. https://doi.org/10.1186/AR2837

    Article  PubMed  PubMed Central  Google Scholar 

  22. Firinu D, Barca MP, Lorrai MM et al (2014) TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome. Autoimmunity 47:389–394. https://doi.org/10.3109/08916934.2014.906582

    Article  CAS  PubMed  Google Scholar 

  23. Vowels BR, Yang S, Leyden JJ (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158–3165. https://doi.org/10.1128/IAI.63.8.3158-3165.1995

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Dan Xu, Liu X, Chengyang Lu, Luo J, Wang C, Gao C, Jianfang Xie XL (2019) Reduction of peripheral natural killer cells in patients with SAPHO syndrome. Clin Exp Rheumatol 37(1):12–18

    Google Scholar 

  25. Trimble BS, Evers CJ, Ballaron SA, Young JM (1987) Intraarticular injection of Propionibacterium acnes causes an erosive arthritis in rats. Agents Actions 21:281–283. https://doi.org/10.1007/BF01966491

    Article  CAS  PubMed  Google Scholar 

  26. Zhang S, Li C, Zhang S et al (2019) Serum levels of proinflammatory, anti-inflammatory cytokines, and RANKL/OPG in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Mod Rheumatol 29:523–530. https://doi.org/10.1080/14397595.2018.1469580

    Article  CAS  PubMed  Google Scholar 

  27. Lachmann HJ (2017) Periodic fever syndromes. Best Pract Res Clin Rheumatol 31:596–609. https://doi.org/10.1016/J.BERH.2017.12.001

    Article  PubMed  Google Scholar 

  28. Leuenberger M, Berner J, Di Lucca J et al (2016) PASS syndrome: an IL-1-Driven autoinflammatory disease. Dermatology 232:254–258. https://doi.org/10.1159/000443648

    Article  CAS  PubMed  Google Scholar 

  29. Sharma M, Ferguson PJ (2013) Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol 25:658–664. https://doi.org/10.1097/BOR.0B013E328363EB08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zhao Y, Ferguson PJ (2018) Chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis in children. Pediatr Clin North Am 65:783–800. https://doi.org/10.1016/J.PCL.2018.04.003

    Article  PubMed  Google Scholar 

  31. Liao HJ, Chyuan IT, Wu CS et al (2015) Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology (Oxford) 54:1317–1326. https://doi.org/10.1093/RHEUMATOLOGY/KEU481

    Article  CAS  PubMed  Google Scholar 

  32. Hurtado-Nedelec M, Chollet-Nartin S, Nicaise-Roland P et al (2008) Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 47:1160–1167. https://doi.org/10.1093/RHEUMATOLOGY/KEN185

    Article  CAS  PubMed  Google Scholar 

  33. Assmann G, Kueck O, Kirchhoff T et al (2009) Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 11(5):R140. https://doi.org/10.1186/AR2812

    Article  PubMed  PubMed Central  Google Scholar 

  34. Colina M, Trotta F (2014) Antibiotics may be useful in the treatment of SAPHO syndrome. Mod Rheumatol 24:697–698. https://doi.org/10.3109/14397595.2013.874760

    Article  PubMed  Google Scholar 

  35. Kikuchi T, Fujii H, Fujita A et al (2018) Mandibular osteitis leading to the diagnosis of SAPHO syndrome. Case Rep Radiol 2018:1–6. https://doi.org/10.1155/2018/9142362

    Article  Google Scholar 

  36. Cao Y, Li C, Yang Q et al (2019) Three patterns of osteoarticular involvement in SAPHO syndrome: a cluster analysis based on whole body bone scintigraphy of 157 patients. Rheumatology (Oxford) 58:1047–1055. https://doi.org/10.1093/RHEUMATOLOGY/KEY415

    Article  PubMed  Google Scholar 

  37. Li C, Ye Y, Cao Y et al (2020) Axial skeletal lesions and disease duration in SAPHO syndrome: a retrospective review of computed tomography findings in 81 patients. Int J Rheum Dis 23:1152–1158. https://doi.org/10.1111/1756-185X.13899

    Article  CAS  PubMed  Google Scholar 

  38. Wolber C, David-Jelinek K, Udvardi A et al (2011) Successful therapy of sacroiliitis in SAPHO syndrome by etanercept. Wien Med Wochenschr 161:204–208. https://doi.org/10.1007/S10354-010-0852-8

    Article  PubMed  Google Scholar 

  39. Van Doornum S, Barraclough D, McColl G, Wicks I (2000) SAPHO: rare or just not recognized? Semin Arthritis Rheum 30:70–77. https://doi.org/10.1053/SARH.2000.8371

    Article  PubMed  Google Scholar 

  40. Kotaki S, Gamoh S, Yoshida H et al (2020) SAPHO syndrome of the temporomandibular joint associated with trismus: a case report and review of the literature. Oral Radiol 36:197–202. https://doi.org/10.1007/S11282-019-00405-1

    Article  PubMed  Google Scholar 

  41. Orui H, Takahara M, Ishikawa A et al (2002) Radiological features of long bones in synovitis, acne, pustulosis, hyperostosis, osteitis syndrome and their correlation with pathological findings. Mod Rheumatol 12:56–63. https://doi.org/10.3109/S101650200009

    Article  CAS  PubMed  Google Scholar 

  42. Naves JE, Cabré E, Mañosa M et al (2013) A systematic review of SAPHO syndrome and inflammatory bowel disease association. Dig Dis Sci 58:2138–2147. https://doi.org/10.1007/S10620-013-2653-6

    Article  CAS  PubMed  Google Scholar 

  43. Carranco-Medina TE, Hidalgo-Calleja C, Calero-Paniagua I et al (2015) Thrombotic manifestations in SAPHO syndrome. Rev Lit Reumatol Clin 11:108–111. https://doi.org/10.1016/j.reuma.2014.07.003

    Article  Google Scholar 

  44. Li C, Liu S, Sui X et al (2018) Pulmonary high-resolution computed tomography findings in patients with synovitis, acne, pustulosis, hyperostosis and osteitis syndrome. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0206858

    Article  PubMed  PubMed Central  Google Scholar 

  45. Valentin R, Gürtler KF, Schaker A (1997) Renal amyloidosis and renal failure–a novel complication of the SAPHO syndrome. Nephrol Dial Transplant 12:2420–2423. https://doi.org/10.1093/NDT/12.11.2420

    Article  CAS  PubMed  Google Scholar 

  46. Heldmann F, Kiltz U, Baraliakos X, Braun J (2014) SAPHO syndrome. Z Rheumatol 73:729–741. https://doi.org/10.1007/S00393-014-1460-6

    Article  CAS  PubMed  Google Scholar 

  47. Baba Y, Weerakkody Y (2010) SAPHO syndrome. Radiopaedia.org, Melbourne. https://doi.org/10.53347/RID-8415

    Book  Google Scholar 

  48. Sudoł-Szopińska I, Jans L, Teh J (2017) Rheumatoid arthritis: what do MRI and ultrasound show. J Ultrason 17:5. https://doi.org/10.15557/JOU.2017.0001

    Article  PubMed  PubMed Central  Google Scholar 

  49. Xu T, Huang Y, Zhao Y et al (2022) 68Ga-DOTA-FAPI-04 PET/CT imaging in a case of SAPHO syndrome. Clin Nucl Med 47:246–248. https://doi.org/10.1097/RLU.0000000000003901

    Article  PubMed  Google Scholar 

  50. Przepiera-Będzak HBM (2016) Antiphospholipid syndrome with Antiβ2glicoprotein-1 antibodies as the cause of recurrent tibial vein thrombosis in SAPHO syndrome. Acta Dermatovenerol Croat 24(4):305306

    Google Scholar 

  51. Okuno H, Watanuki M, Kuwahara Y et al (2018) Clinical features and radiological findings of 67 patients with SAPHO syndrome. Mod Rheumatol 28:703–708. https://doi.org/10.1080/14397595.2017.1372874

    Article  PubMed  Google Scholar 

  52. Li C, Xiang Y, Wu X et al (2020) Serum IgG4 elevation in SAPHO syndrome: does it unmask a disease activity marker? Clin Exp Rheumatol 38:35–41

    PubMed  Google Scholar 

  53. Fu Z, Liu M, Li Z et al (2016) Is the bullhead sign on bone scintigraphy really common in the patient with SAPHO syndrome? A single-center study of a 16-year experience. Nucl Med Commun 37:387–392. https://doi.org/10.1097/MNM.0000000000000451

    Article  PubMed  Google Scholar 

  54. Ferguson PJ, Sandu M (2012) Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 14:130–141. https://doi.org/10.1007/S11926-012-0239-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Schilling F, Kessler S (2000) SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases. Z Rheumatol 59:1–28. https://doi.org/10.1007/S003930050001

    Article  CAS  PubMed  Google Scholar 

  56. Edwin J, Ahmed S, Verma S et al (2018) Swellings of the sternoclavicular joint: review of traumatic and non-traumatic pathologies. EFORT open Rev 3:471–484. https://doi.org/10.1302/2058-5241.3.170078

    Article  PubMed  PubMed Central  Google Scholar 

  57. Rosenberg M, Conermann T (2022) Tietze syndrome. StatPearls, Treasure Island

    Google Scholar 

  58. Paice EW, Wright FW, Hill AGS (1983) Sternoclavicular erosions in polymyalgia rheumatica. Ann Rheum Dis 42:379–383. https://doi.org/10.1136/ARD.42.4.379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Carroll MB (2011) Sternocostoclavicular hyperostosis: a review. Ther Adv Musculoskelet Dis 3:101–110. https://doi.org/10.1177/1759720X11398333

    Article  PubMed  PubMed Central  Google Scholar 

  60. Himuro H, Kurata S, Nagata S et al (2020) Imaging features in patients with SAPHO/CRMO: a pictorial review. Jpn J Radiol 38:622–629. https://doi.org/10.1007/S11604-020-00953-1

    Article  PubMed  Google Scholar 

  61. Jurik AG, Klicman RF, Simoni P et al (2018) SAPHO and CRMO: the Value of Imaging. Semin Musculoskelet Radiol 22:207–224. https://doi.org/10.1055/S-0038-1639469

    Article  PubMed  Google Scholar 

  62. Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco SR (2016) SAPHO syndrome: current developments and approaches to clinical treatment. Curr Rheumatol Rep 18(6):35. https://doi.org/10.1007/S11926-016-0583-Y

    Article  PubMed  Google Scholar 

  63. Figueiredo ASB, Oliveira AL, Caetano A, Moraes-Fontes MF (2020) SAPHO: has the time come for tailored therapy? Clin Rheumatol 39:177–187. https://doi.org/10.1007/S10067-019-04675-2

    Article  PubMed  Google Scholar 

  64. Hussain A, Gondal M, Abdallah N et al (2020) Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO): an interesting clinical syndrome. Cureus 12(9):e10184. https://doi.org/10.7759/CUREUS.10184

    Article  PubMed  PubMed Central  Google Scholar 

  65. Jung J, Molinger M, Kohn D et al (2012) Intra-articular glucocorticosteroid injection into sternocostoclavicular joints in patients with SAPHO syndrome. Semin Arthritis Rheum 42:266–270. https://doi.org/10.1016/J.SEMARTHRIT.2012.03.012

    Article  CAS  PubMed  Google Scholar 

  66. Huang H, Zhang Z, Zhao J et al (2021) The effectiveness of treatments for patients with SAPHO syndrome: a follow-up study of 24 cases from a single center and review of literature. Clin Rheumatol 40:1131–1139. https://doi.org/10.1007/S10067-020-05322-X

    Article  PubMed  Google Scholar 

  67. Wang CR, Tsai YS, Whang-Peng J (2020) Zoledronic acid monotherapy improves osteoarticular involvement in SAPHO syndrome. Scand J Rheumatol 49:419–421. https://doi.org/10.1080/03009742.2020.1769179

    Article  CAS  PubMed  Google Scholar 

  68. Colina M, La Corte R, Trotta F (2009) Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 27(1):112–115

    CAS  PubMed  Google Scholar 

  69. Li C, Zhao Y, Zuo Y et al (2019) Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study. Clin Exp Rheumatol 37(4):663–669

    PubMed  Google Scholar 

  70. Liu S, Yin D, Lin Z et al (2023) Short-term efficacy of zoledronic acid in the treatment of 30 cases of SAPHO syndrome. Clin Exp Rheumatol. https://doi.org/10.55563/CLINEXPRHEUMATOL/ZPGYZ9

    Article  PubMed  Google Scholar 

  71. Zwaenepoel T, de Vlam K (2016) SAPHO: treatment options including bisphosphonates. Semin Arthritis Rheum 46:168–173. https://doi.org/10.1016/j.semarthrit.2016.04.004

    Article  CAS  PubMed  Google Scholar 

  72. Cheng W, Li F, Tian J et al (2022) New Insights in the treatment of SAPHO syndrome and medication recommendations. J Inflamm Res 15:2365. https://doi.org/10.2147/JIR.S353539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Wang L, Sun B, Li C (2021) Clinical and radiological remission of osteoarticular and cutaneous lesions in SAPHO patients treated with secukinumab: a case series. J Rheumatol 48:953–955. https://doi.org/10.3899/JRHEUM.201260

    Article  PubMed  Google Scholar 

  74. Daoussis D, Konstantopoulou G, Kraniotis P et al (2019) Biologics in SAPHO syndrome: a systematic review. Semin Arthritis Rheum 48:618–625. https://doi.org/10.1016/J.SEMARTHRIT.2018.04.003

    Article  CAS  PubMed  Google Scholar 

  75. Wendling D, Aubin F, Verhoeven F, Prati C (2017) IL-23/Th17 targeted therapies in SAPHO syndrome. A case series. Jt bone spine 84:733–735. https://doi.org/10.1016/J.JBSPIN.2017.05.016

    Article  CAS  Google Scholar 

  76. Xia RY, Diao ZY, Zhang ZQ et al (2022) Successful treatment of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with ixekizumab. Clin Exp Dermatol 47:978–980. https://doi.org/10.1111/CED.15087

    Article  PubMed  Google Scholar 

  77. Licata G, Gambardella A, Calabrese G et al (2021) SAPHO syndrome successful treated with tildrakizumab. Dermatol Ther 34(1):e14758. https://doi.org/10.1111/DTH.14758

    Article  CAS  PubMed  Google Scholar 

  78. Li Y, Huo J, Cao Y et al (2020) Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. Ann Rheum Dis 79:1255–1257. https://doi.org/10.1136/ANNRHEUMDIS-2020-217250

    Article  PubMed  Google Scholar 

  79. Sun XC, Liu S, Li C et al (2018) Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report. J Int Med Res 46:5309–5315. https://doi.org/10.1177/0300060518806105

    Article  PubMed  PubMed Central  Google Scholar 

  80. Adamo S, Nilsson J, Krebs A et al (2018) Successful treatment of SAPHO syndrome with apremilast. Br J Dermatol 179:959–962. https://doi.org/10.1111/BJD.16071

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Faculty of Medicine, Dokuz Eylul University, Balçova/İzmir, Turkey

    Tuba Demirci Yildirim & İsmail Sari

Authors
  1. Tuba Demirci Yildirim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. İsmail Sari
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TDY and İS participated in the design of the study, carried out the literature search and selection process, and drafted the paper. All the authors participated in modelling the data, drafting the paper and reading and approving the final version of this manuscript. All authors take full responsibility for the integrity of all aspects of the work.

Corresponding author

Correspondence to Tuba Demirci Yildirim.

Ethics declarations

Conflict of interest

The authors have no conflict of interests to declare.

Ethical approval

For this study ethical approval is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demirci Yildirim, T., Sari, İ. SAPHO syndrome: current clinical, diagnostic and treatment approaches. Rheumatol Int (2023). https://doi.org/10.1007/s00296-023-05491-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00296-023-05491-3

Keywords

Search

Navigation